Ethyl pyruvate reduces liver injury at early phase but impairs regeneration at late phase in acetaminophen overdose
Open Access
- 16 January 2012
- journal article
- Published by Springer Nature in Critical Care
- Vol. 16 (1) , R9
Abstract
Introduction: Inflammation may critically affect mechanisms of liver injury in acetaminophen (APAP) hepatotoxicity. Kupffer cells (KC) play important roles in inflammation, and KC depletion confers protection at early time points after APAP treatment but can lead to more severe injury at a later time point. It is possible that some inflammatory factors might contribute to liver damage at an early injurious phase but facilitate liver regeneration at a late time point. Therefore, we tested this hypothesis by using ethyl pyruvate (EP), an anti-inflammatory agent, to treat APAP overdose for 24-48 hours. Methods: C57BL/6 male mice were intraperitoneally injected with a single dose of APAP (350 mg/kg dissolved in 1 mL sterile saline). Following 2 hours of APAP challenge, the mice were given 0.5 mL EP (40 mg/kg) or saline treatment every 8 hours for a total of 24 or 48 hours. Results: Twenty-four hours after APAP challenge, compared to the saline-treated group, EP treatment significantly lowered serum transaminases (ALT/AST) and reduced liver injury seen in histopathology; however, at the 48-hour time point, compared to the saline therapy, EP therapy impaired hepatocyte regeneration and increased serum AST; this late detrimental effect was associated with reduced serum TNF-α concentration and decreased expression of cell cycle protein cyclin D1, two important factors in liver regeneration. Conclusions: Inflammation likely contributes to liver damage at an early injurious phase but improves hepatocyte regeneration at a late time point, and prolonged anti-inflammation therapy at a late phase is not beneficial.Keywords
This publication has 30 references indexed in Scilit:
- Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in miceToxicology and Applied Pharmacology, 2003
- Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in miceJournal of Laboratory and Clinical Medicine, 2003
- The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in miceJournal of Leukocyte Biology, 2003
- Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic MonolayersThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Protective Role of Kupffer Cells in Acetaminophen-Induced Hepatic Injury in MiceChemical Research in Toxicology, 2002
- Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammationProceedings of the National Academy of Sciences, 2002
- Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shockAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Transcriptional activation of heme oxygenase-1 and its functional significance in acetaminophen-induced hepatitis and hepatocellular injury in the ratJournal of Hepatology, 2000
- L-Selectin and Chemokine Response after Liver Ischemia and ReperfusionJournal of Surgical Research, 2000
- Liver regenerationJournal of Hepatology, 2000